186 related articles for article (PubMed ID: 20937788)
1. Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.
Shang S; Shanley CA; Caraway ML; Orme EA; Henao-Tamayo M; Hascall-Dove L; Ackart D; Lenaerts AJ; Basaraba RJ; Orme IM; Ordway DJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):124-31. PubMed ID: 20937788
[TBL] [Abstract][Full Text] [Related]
2. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis.
Andries K; Gevers T; Lounis N
Antimicrob Agents Chemother; 2010 Nov; 54(11):4540-4. PubMed ID: 20713662
[TBL] [Abstract][Full Text] [Related]
4. Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Tasneen R; Li SY; Peloquin CA; Taylor D; Williams KN; Andries K; Mdluli KE; Nuermberger EL
Antimicrob Agents Chemother; 2011 Dec; 55(12):5485-92. PubMed ID: 21930883
[TBL] [Abstract][Full Text] [Related]
5. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
[TBL] [Abstract][Full Text] [Related]
6. Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis.
Veziris N; Ibrahim M; Lounis N; Andries K; Jarlier V
PLoS One; 2011 Mar; 6(3):e17556. PubMed ID: 21408613
[TBL] [Abstract][Full Text] [Related]
7. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.
De Groote MA; Gilliland JC; Wells CL; Brooks EJ; Woolhiser LK; Gruppo V; Peloquin CA; Orme IM; Lenaerts AJ
Antimicrob Agents Chemother; 2011 Mar; 55(3):1237-47. PubMed ID: 21135176
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
Rosenthal IM; Zhang M; Almeida D; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2008 Nov; 178(9):989-93. PubMed ID: 18723432
[TBL] [Abstract][Full Text] [Related]
11. Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.
Zhang T; Li SY; Williams KN; Andries K; Nuermberger EL
Am J Respir Crit Care Med; 2011 Sep; 184(6):732-7. PubMed ID: 21659613
[TBL] [Abstract][Full Text] [Related]
12. Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Williams K; Minkowski A; Amoabeng O; Peloquin CA; Taylor D; Andries K; Wallis RS; Mdluli KE; Nuermberger EL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3114-20. PubMed ID: 22470112
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Zhang M; Li SY; Rosenthal IM; Almeida DV; Ahmad Z; Converse PJ; Peloquin CA; Nuermberger EL; Grosset JH
Am J Respir Crit Care Med; 2011 May; 183(9):1254-61. PubMed ID: 21330452
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
Ahmad Z; Fraig MM; Bisson GP; Nuermberger EL; Grosset JH; Karakousis PC
Antimicrob Agents Chemother; 2011 Apr; 55(4):1527-32. PubMed ID: 21282447
[TBL] [Abstract][Full Text] [Related]
15. Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Swanson RV; Ammerman NC; Ngcobo B; Adamson J; Moodley C; Dorasamy A; Moodley S; Mgaga Z; Bester LA; Singh SD; Almeida DV; Grosset JH
Antimicrob Agents Chemother; 2016 May; 60(5):2864-9. PubMed ID: 26926638
[TBL] [Abstract][Full Text] [Related]
16. Experimental ocular tuberculosis in guinea pigs.
Rao NA; Albini TA; Kumaradas M; Pinn ML; Fraig MM; Karakousis PC
Arch Ophthalmol; 2009 Sep; 127(9):1162-6. PubMed ID: 19752425
[TBL] [Abstract][Full Text] [Related]
17. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
[TBL] [Abstract][Full Text] [Related]
18. Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
Dutta NK; Alsultan A; Gniadek TJ; Belchis DA; Pinn ML; Mdluli KE; Nuermberger EL; Peloquin CA; Karakousis PC
Antimicrob Agents Chemother; 2013 Aug; 57(8):3910-6. PubMed ID: 23733473
[TBL] [Abstract][Full Text] [Related]
19. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
[TBL] [Abstract][Full Text] [Related]
20. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
Matteelli A; Carvalho AC; Dooley KE; Kritski A
Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]